Order Article Reprints

Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Araya T, Hiraoka N, Ishizuka T, Takeda T, Kawasaki M, Goto Y, et al. Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment. Journal of Clinical Medicine. 2020; 9(6):1762. https://doi.org/10.3390/jcm9061762

Nakao, Akira, Osamu Hiranuma, Junji Uchino, Chikara Sakaguchi, Tomoyuki Araya, Noriya Hiraoka, Tamotsu Ishizuka, Takayuki Takeda, Masayuki Kawasaki, Yasuhiro Goto, and et al. 2020. "Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment" Journal of Clinical Medicine 9, no. 6: 1762. https://doi.org/10.3390/jcm9061762

Nakao, A., Hiranuma, O., Uchino, J., Sakaguchi, C., Araya, T., Hiraoka, N., Ishizuka, T., Takeda, T., Kawasaki, M., Goto, Y., Imai, H., Hattori, N., Nakatomi, K., Uramoto, H., Uryu, K., Fukuda, M., Uchida, Y., Yokoyama, T., Akai, M., ... Takayama, K. (2020). Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment. Journal of Clinical Medicine, 9(6), 1762. https://doi.org/10.3390/jcm9061762